Sustainable Cytopathology in the Precision Medicine Era: Exploring New Sources for Molecular Testing in Thyroid Cytology Specimens

Cancer cytopathology - United States
doi 10.1002/cncy.22107
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

P3.01-78 the Cytology Samples and Plasma Specimens Were Feasible for the EGFR Molecular Testing.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Radiopharmaceutical Therapy in the Era of Precision Medicine

European Journal of Cancer
Cancer ResearchOncology
2014English

Structural Valve Degeneration in the Era of Precision Medicine

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

The Role of Cytology in Molecular Testing and Personalized Medicine in Lung Cancer: A Clinical Perspective

Cancer cytopathology
Cancer ResearchOncology
2018English

New Clinical Trial Designs for Establishing Drug Efficacy and Safety in a Precision Medicine Era

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Retrospective Study of Fine Needle Aspiration Cytology of Thyroid Lesions According to the Bethesda System for Reporting Thyroid Cytopathology in El-Beida City

Saudi Journal of Biomedical Research
2019English

The Bethesda System for Reporting Thyroid Cytopathology

Thyroid
MedicineEndocrinologyMetabolismDiabetes
2009English

Molecular Cytopathology for Thyroid Nodules: A Review of Methodology and Test Performance

Cancer cytopathology
Cancer ResearchOncology
2015English

Sources of Bias in Specimens for Research About Molecular Markers for Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy